rs386833986
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_007035.4(KERA):c.835C>T(p.Arg279Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,609,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
KERA
NM_007035.4 stop_gained
NM_007035.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 0.684
Genes affected
KERA (HGNC:6309): (keratocan) The protein encoded by this gene is a keratan sulfate proteoglycan that is involved in corneal transparency. Defects in this gene are a cause of autosomal recessive cornea plana 2 (CNA2).[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-91055447-G-A is Pathogenic according to our data. Variant chr12-91055447-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 56550.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-91055447-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KERA | NM_007035.4 | c.835C>T | p.Arg279Ter | stop_gained | 2/3 | ENST00000266719.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KERA | ENST00000266719.4 | c.835C>T | p.Arg279Ter | stop_gained | 2/3 | 1 | NM_007035.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151024Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249380Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134796
GnomAD3 exomes
AF:
AC:
3
AN:
249380
Hom.:
AF XY:
AC XY:
3
AN XY:
134796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1458962Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 725782
GnomAD4 exome
AF:
AC:
28
AN:
1458962
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
725782
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000397 AC: 6AN: 151024Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73714
GnomAD4 genome
AF:
AC:
6
AN:
151024
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
73714
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cornea plana 2 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 21, 2016 | - - |
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Nov 26, 2018 | [ACMG/AMP: PVS1, PM2, PS4_Moderate, PP1] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is absent from or rarely observed in large-scale population databases [PM2], has previously been observed in multiple unrelated patients with the same phenotype [PS4_Moderate], has been shown to cosegregate with disease in multiple affected family members [PP1]. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56550). This premature translational stop signal has been observed in individuals with cornea plana (PMID: 16234475, 23834557). This variant is present in population databases (rs386833986, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg279*) in the KERA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KERA are known to be pathogenic (PMID: 10802664, 16234475, 31059048). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at